Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase and HAT activities
about
Metabolism, cytoskeleton and cellular signalling in the grip of protein Nepsilon - and O-acetylationHexosamines, insulin resistance, and the complications of diabetes: current status.Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauerThe C-terminal domain of the nuclear factor I-B2 isoform is glycosylated and transactivates the WAP gene in the JEG-3 cellsO-GlcNAcylation, an Epigenetic Mark. Focus on the Histone Code, TET Family Proteins, and Polycomb Group ProteinsFunctional O-GlcNAc modifications: implications in molecular regulation and pathophysiologyProteome wide purification and identification of O-GlcNAc-modified proteins using click chemistry and mass spectrometrySynergy of Peptide and Sugar in O-GlcNAcase Substrate RecognitionStructure of a bacterial putative acetyltransferase defines the fold of the human O-GlcNAcase C-terminal domainThree-dimensional structure of aStreptomyces sviceusGNAT acetyltransferase with similarity to the C-terminal domain of the human GH84O-GlcNAcaseO-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter?A moonlighting metabolic protein influences repair at DNA double-stranded breaks.HATs and HDACs: from structure, function and regulation to novel strategies for therapy and preventionThe hexosamine signaling pathway: deciphering the "O-GlcNAc code"Structure and mechanism of a bacterial beta-glucosaminidase having O-GlcNAcase activityNuclear localization of STAT5A modified with O-linked N-acetylglucosamine and early involution in the mammary gland of Hirosaki hairless ratO-GlcNAcase: promiscuous hexosaminidase or key regulator of O-GlcNAc signaling?Evidence for a Functional O-Linked N-Acetylglucosamine (O-GlcNAc) System in the Thermophilic Bacterium Thermobaculum terrenumPost-translational modifications of the cardiac proteome in diabetes and heart failureThe hexosamine signaling pathway: O-GlcNAc cycling in feast or famineO-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stressToxic effects of hyperglycemia are mediated by the hexosamine signaling pathway and o-linked glycosylation in early mouse embryos.Dynamic O-GlcNAc cycling at promoters of Caenorhabditis elegans genes regulating longevity, stress, and immunity.O-GlcNAcylation/phosphorylation cycling at Ser10 controls both transcriptional activity and stability of delta-lactoferrin.O-GlcNAc signaling in the cardiovascular system.O-GlcNAcylation determines the solubility, filament organization, and stability of keratins 8 and 18Blocking O-linked GlcNAc cycling in Drosophila insulin-producing cells perturbs glucose-insulin homeostasis.Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development.O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension.Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysisO-GlcNAcylation: a novel pathway contributing to the effects of endothelin in the vasculature.Protein O-GlcNAcylation and cardiovascular (patho)physiology.Muscle-specific overexpression of NCOATGK, splice variant of O-GlcNAcase, induces skeletal muscle atrophy.A lipid-droplet-targeted O-GlcNAcase isoform is a key regulator of the proteasomeA little sugar goes a long way: the cell biology of O-GlcNAc.Modification of histones by sugar β-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulatedChemical approaches to understanding O-GlcNAc glycosylation in the brain.O-GlcNAc signalling: implications for cancer cell biology.Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.
P2860
Q24307834-A42B0FDC-9DF3-4BAB-AA4B-6F5733985561Q24538581-1F868D11-EBD9-4AE1-8A89-BA986D3AD485Q24670972-5147BE6C-0B9E-4BA7-AD5C-9DC1F998EE9CQ24681259-81302B47-2599-4710-A26A-DFDC0FEE02BCQ26822661-ED8DF19F-8A48-4802-9172-FB46AD1CC57BQ27009399-0DAF51BD-CA3B-4841-90E9-F20AEF8E37FCQ27334695-D9E43C7D-FA40-495B-86E0-8D084819F7AAQ27677479-DFA45805-21E9-4274-86BF-FCCAB7494CA3Q27680132-8F692F0F-90A1-4245-99B7-C415E3655186Q27681305-0EB6EFF4-2084-4FC9-BC58-85A9F691DE6FQ27693206-3D544A37-DFFA-4BFA-B410-1F40EDF3620AQ27935930-83F0A03F-DA46-4280-AB74-9C07289F3C11Q28240437-C02EEB67-C465-4BCA-A337-3C1E3475F7F8Q28284365-D9DE0CD0-A666-4EA7-B8CD-2C183A1F8135Q28492135-5795DACB-1E03-4881-ADBC-23E5C9E6B538Q28573662-6357693E-BB34-4DBB-A72E-174B70A0F9A4Q30368002-3B4915D6-E8D5-4931-8C9F-CDD2A837151BQ30380552-095933A2-C3D6-4A29-AD13-FDF41DB3BA79Q33361067-7463CD58-AB2D-4AE8-A4D2-F4DAFB3F55F2Q33625053-AEBBDD43-1101-4B95-90CB-B18524300319Q33625265-0ED6E138-2D55-429F-B6AD-F2DB4D00BA68Q33742336-F3D2EE53-25C3-421F-9DD7-CC8741A75E13Q33842100-72D8FEB0-6CE7-4958-AB00-5D3863FC86B9Q33911287-149A052E-9006-4DBB-A085-A21C0E9937D2Q34056858-9179D16A-950A-4909-B1CA-CD00744B4C49Q34232124-AE18E7B1-C8C2-4CF1-8CE3-BC4D2C3E8F7FQ34352417-9F1314AD-E3FF-4D3C-A28F-3F6405015378Q34498017-E38B18E8-B478-4AC0-BB2A-323721E2AA24Q34498193-DE1A88A9-A3DF-4581-86DD-84AEAF87F7A1Q34502637-ECE68D7C-E22B-433B-AC50-A759B53DCC54Q34598611-8530B4EA-BEAC-4D70-B385-DA4A38C1EEE5Q34683061-5C8760AD-7030-4B2A-A1A2-9F0A5F05D950Q34718031-405CBD97-2524-4B0C-A283-2EC99CDF3978Q35140884-5A7440F8-2D91-4BD6-81E4-8C811518E578Q35261648-3D6C9232-1394-4317-80E8-41D8589C78F5Q35423830-9A1C0212-1FE3-43B4-9D73-CB161A3F3A33Q35648339-E6BCD6B7-501E-474A-A82B-2965E4FE9343Q35793071-B77017CC-CE96-4595-A372-473D8B13080AQ35804446-878A2B6B-6C80-4557-80D1-B2EEEAB69F26Q35994096-16D3D359-9AED-4CEC-B096-3D56F25DB42E
P2860
Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase and HAT activities
description
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2004
@ast
im Dezember 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/12/17)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/12/17)
@nl
наукова стаття, опублікована в грудні 2004
@uk
name
Characterization of the histon ...... O-GlcNAcase and HAT activities
@ast
Characterization of the histon ...... O-GlcNAcase and HAT activities
@en
Characterization of the histon ...... O-GlcNAcase and HAT activities
@nl
type
label
Characterization of the histon ...... O-GlcNAcase and HAT activities
@ast
Characterization of the histon ...... O-GlcNAcase and HAT activities
@en
Characterization of the histon ...... O-GlcNAcase and HAT activities
@nl
prefLabel
Characterization of the histon ...... O-GlcNAcase and HAT activities
@ast
Characterization of the histon ...... O-GlcNAcase and HAT activities
@en
Characterization of the histon ...... O-GlcNAcase and HAT activities
@nl
P2093
P356
P1476
Characterization of the histon ...... O-GlcNAcase and HAT activities
@en
P2093
Andrew J. Paterson
Clifford Toleman
Jeffrey E. Kudlow
Thomas R. Whisenhunt
P304
53665–53673
P356
10.1074/JBC.M410406200
P407
P577
2004-12-17T00:00:00Z